Skip to main content

Search
Profile

Russ Geyer, MD

|
Russ Geyer, MD

Hematology-Oncology

On staff since June 1986

Children's Title: In-patient Clinical Director; Evans Family Endowed Chair in Pediatric Cancer

Academic Title: Professor, Pediatrics

Research Center: Center for Clinical and Translational Research

Recommendations

HeatherRedmond, WA07.10.13
Dr. Geyer was the Oncologist on-call when our daughter was diagnosed with Neuroblastoma at 9 months old. She had lost all neurologic function below the waist, which was an emergent situation. Dr. Geyer moved from MRI, Diagnosis and treatment so rapidly; it was really impressive. Within hours we were checked into a room and my daughter was receiving her first dose of chemo. Nothing ever prepares you to hear that your child has cancer, but Dr. Geyer handled himself with such professionalism, kindness and compassion. He helped answer our immediate questions and let us know how the process would work along with who our doctors and nurses would be. I am so grateful that he reacted so quickly and with such urgency for our daughter.
KendraRonan, MT10.08.11
Dr Geyer and Nurse, Cory, embodied the best of medicine in through my son Hudson's fight with a brain tumor. Their compassionate communication and management of cutting edge treatments empowered us to make the best of a heart breaking situation. I give credit to the staff at Childrens' in Seattle for the cherished extra time we were able to spend with Hudson. The cares we received inspired me to go on to nursing school after our loss. I am now an Obstetrics and Medical/Surgical R.N. in our local facility, caring for laboring moms, thier infants, and a lifespan of surgical patients. The team went over and above the call of duty to be deeply instrumental in our treatment, continued healing as we "pay it forward".
TanyaRichland, WA03.15.11
Dr. Geyer was our son Aidan's Oncologist during his 2 1/2 year battle with DIPG. His knowledge and care of Aidan went above and beyond what was required of him. He managed to always be truthful and compassionate with the information and decisions that were given to us. We will never be able to thank him and his team enough for the care they gave to Aidan until the end. He will always be one of Aidan's Angels!
JonKetchikan01.19.11
Dr. Geyer is awesome. He is very friendly, and extremely knowledgeable in his field. I am so glad to have had Dr. Geyer in my life. If it weren't for him, who know if I'd be here.
WilbertBellevue, WA09.13.12
Dr. Geyer is awesome. And Cory too. Our son was diagnosed (Glioblastoma Multiforme) when he was 17 months old, and he was lucky that Dr. Geyer took him (well us) under his wing as him primary oncologist. Dr. Geyer always gave us the impression that he would fight for Niels' life, and that we were part of it, always super friendly, super clear, and always taking our floods of questions seriously. Seriously, I don't know what more we could have wished for in his medical team. More than 3 years later, Niels is alive & happy, and the tumor seems to be gone from the MRIs.
Recommend Dr. Russ Geyer

Overview

Board Certification(s)
Pediatric Hematology-Oncology
Pediatrics
Medical/Professional School
Wayne State University School of Medicine, Detroit
Residency
Pediatrics, Children's Hospital of Michigan, Detroit
Child Neurology, University of Michigan Hospital, Ann Arbor
Pediatric Hematology-Oncology, University of Washington School of Medicine, Seattle
Research Description

Pediatric Oncology

Research Focus Area

Cancer

Awards and Honors

Award NameAward DescriptionAwarded ByAward Date
Seattle Magazine Top Doctor - 2012Seattle Magazine Top Doctor - 2012Seattle Magazine 2012
U.S. News Top DoctorU.S. News and World Report 2012
"Guide to America's Top Pediatricians"Consumer's Research Council of America 2009
Department of Pediatrics Faculty Mentor AwardUniversity of Washington 2007
Alpha Omega Alpha SocietyWayne State University 1976
Sophomore Medical Scholarship AwardWayne State University 1975

Publications

Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery , 2013 Nov: 29(11)2071-7
A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
Journal of neuro-oncology , 2013 Sep: 114(2)173-9
Economic Impact of Advanced Pediatric Cancer on Families.
Journal of pain and symptom management , 2013 Jul 18
Gross total resection correlates with long-term survival in pediatric patients with glioblastoma.
World neurosurgery , 2013 Mar-Apr: 79(3-4)537-44
Communicating and understanding the purpose of pediatric phase I cancer trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2012 Dec 10: 30(35)4367-72
Epilepsy surgery after treatment of pediatric malignant brain tumors.
Seizure : the journal of the British Epilepsy Association , 2012 Oct: 21(8)624-30
Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).
Journal of neuro-oncology , 2012 Sep: 109(3)565-71
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
Journal of neuro-oncology , 2012 Feb: 106(3)643-9
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2011 Oct 20: 29(30)3999-4006
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.
Neuro-oncology , 2011 Mar: 13(3)298-306
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
Neuro-oncology , 2011 Mar: 13(3)290-7
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
European journal of cancer (Oxford, England : 1990) , 2010 Dec: 46(18)3287-93
MRI changes associated with vigabatrin treatment mimicking tumor progression.
Pediatric blood & cancer , 2010 Dec 1: 55(6)1221-3
Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.
Cancer , 2010 Oct 1: 116(19)4632-7
Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma.
Journal of pediatric hematology/oncology , 2010 Aug: 32(6)515-8
DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
NeuroImage , 2010 Aug 1: 52(1)217-23
Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib.
European journal of cancer (Oxford, England : 1990) , 2010 Jul: 46(11)2045-51
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
Pediatric blood & cancer , 2009 Feb: 52(2)169-76
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
Pediatric blood & cancer , 2008 Dec: 51(6)806-11
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
Neuro-oncology , 2008 Jun: 10(3)341-7
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2007 Jul 20: 25(21)3137-43
Adrenocorticotropin-secreting pancreatoblastoma.
Journal of pediatric endocrinology & metabolism : JPEM , 2007 May: 20(5)639-42
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
Neuro-oncology , 2007 Apr: 9(2)145-60
Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature.
Journal of neurosurgery , 2006 Dec: 105(6 Suppl)508-14
Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients.
Cancer investigation , 2006 Apr-May: 24(3)310-7
Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas.
Journal of pediatric hematology/oncology , 2006 Jan: 28(1)36-9
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Oct 20: 23(30)7621-31
Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research , 2005 Oct 15: 11(20)7405-14
O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research , 2005 Apr 1: 11(7)2747-55
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Mar 1: 23(7)1555-63
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Jan 20: 23(3)525-31
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Jan 20: 23(3)525-31
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Pediatric blood & cancer , 2004 Oct: 43(5)571-9
Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
International journal of radiation oncology, biology, physics , 2004 Mar 15: 58(4)1161-4
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2003 Jan 1: 21(1)143-7
A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
Neuro-oncology , 2003 Jan: 5(1)8-13
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
Journal of pediatric hematology/oncology , 2002 Jun-Jul: 24(5)337-42

Research Funding

Grant TitleGrantorAmountAward Date
U10 CA98543 National Childhood Cancer Foundation-NIH/NCI $$1,367,150.Jan. 1, 2003 - Feb. 29, 2008
FH #05-103637-03-S0993FHCRC Damon Runyan $$995,000.Jan. 1, 2002 - June 30, 2007

Primary Office

Seattle Children's
MB.8.501 - Hematology-Oncology
4800 Sand Point Way NE
Seattle, WA 98105
206-987-2106

Find a Doctor or Researcher

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

Doctor or Researcher Name:

More search options